New drug extends lung cancer survival 22 percent
With bortezomib plus standard care, patients with advanced lung cancer lived 11 months
read more | digg story
read more | digg story
My daily Diggss... by the guy who did 24 The Podcast
1 Comments:
Super color scheme, I like it! Good job. Go on.
»
Post a Comment
<< Home